Login

Anhydrol Forte 20% w/v Cutaneous Solution

*
Pharmacy Only: Non-prescription

Updated on 30 September 2024

File name

ANHF-IPHA.PIL.QP26-245-1.pdf

Reasons for updating

  • Change to section 4 - how to report a side effect
  • Change to section 6 - date of revision

Free text change information supplied by the pharmaceutical company

section 4 insert after "directly" Via HPRA Pharmacovigilance website: WWW.HPRA.IE

Updated on 23 January 2023

File name

ANHF-IPHA.SPC.pdf

Reasons for updating

  • Document format updated

Legal category:Supply through pharmacy only

Updated on 17 December 2020

File name

ANHF-IPHA.SPC.pdf

Reasons for updating

  • Change to section 7 - Marketing authorisation holder
  • Change to section 8 - Marketing authorisation number(s)
  • Change to section 10 - Date of revision of the text

Legal category:Supply through pharmacy only

Updated on 31 August 2018

File name

ANHF-IPHA.SPC.10.07.15.14.07.15.pdf

Reasons for updating

  • File format updated to PDF

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

File format updated to PDF

Updated on 14 July 2015

File name

PIL_8637_774.pdf

Reasons for updating

  • New PIL for new product

Updated on 14 July 2015

Reasons for updating

  • New SPC for new product

Legal category:Supply through pharmacy only

Updated on 14 July 2015

Reasons for updating

  • Change to Section 4.8 – Undesirable effects - how to report a side effect
  • Change to section 10 - Date of revision of the text
  • Improved electronic presentation

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

In section 4.8 Undesirable effects, the following text has been added:

Reporting of suspected adverse reactions

Reporting suspected adverse reactions after authorisation of the medicinal product is important.  It allows continued monitoring of the benefit/risk balance of the medicinal product.  Healthcare professionals are asked to report any suspected adverse reactions via HPRA Pharmacovigilance, Earlsfort Terrace, IRL – Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517.  Website: www.hpra.ie; E-mail: medsafety@hpra.ie.



In section 10 Date of revision of the text, the date has changed to "June 2015"

Updated on 14 July 2015

Reasons for updating

  • Change to date of revision
  • Addition of information on reporting a side effect.

Updated on 21 August 2014

Reasons for updating

  • Change to date of revision
  • Removal/change of distributor

Updated on 26 June 2009

Reasons for updating

  • Change due to user-testing of patient information

Updated on 29 August 2007

Reasons for updating

  • Change of trade or active ingredient name

Updated on 13 August 2007

Reasons for updating

  • Change to section 6.5 - Nature and contents of container

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Section 6.5 - Nature and contents of container: The text 'This is supplied as an original pack (OP)' has been removed.

Updated on 17 April 2007

Reasons for updating

  • Change to section 1 - Name of medicinal product

Legal category:Supply through pharmacy only

Free text change information supplied by the pharmaceutical company

Section 1 - Name of the Medicinal Product: The name has changed from "Anhydrol Forte" to "Anhydrol Forte 20% w/v Cutaneous Solution".

Updated on 03 September 2004

Reasons for updating

  • New PIL for medicines.ie

Updated on 12 June 2003

Reasons for updating

  • Change to section 6.3 - Shelf life
  • Change to section 9 - Date of renewal of authorisation

Legal category:Supply through pharmacy only

Updated on 09 June 2003

Reasons for updating

  • New SPC for medicines.ie

Legal category:Supply through pharmacy only